dc.creator |
Gitanjali B |
|
dc.creator |
Raveendran R |
|
dc.creator |
Pandian D |
|
dc.creator |
Sujindra S |
|
dc.date |
2003 |
|
dc.date.accessioned |
2013-05-30T11:22:14Z |
|
dc.date.available |
2013-05-30T11:22:14Z |
|
dc.date.issued |
2013-05-30 |
|
dc.identifier |
http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2003;volume=49;issue=2;spage=109;epage=13;aulast=Gitanjali |
|
dc.identifier |
http://www.doaj.org/doaj?func=openurl&genre=article&issn=00223859&date=2003&volume=49&issue=2&spage=109 |
|
dc.identifier.uri |
http://koha.mediu.edu.my:8181/jspui/handle/123456789/4548 |
|
dc.description |
CONTEXT: Researchers and investigators have argued that getting fully informed written consent may not be possible in the developing countries where illiteracy is widespread. AIMS: To determine the percentage of patients who agree to participate in a trial after receiving either complete or partial information regarding a trial and to find out whether there were gender or educational status-related differences. To assess reasons for consenting or refusing and their depth of understanding of informed consent. SETTINGS AND DESIGN: A simulated clinical trial in two tertiary health care facilities on in-patients. METHODS AND MATERIAL: An informed consent form for a mock clinical trial of a drug was prepared. The detailed / partial procedure was explained to a purposive sample of selected in-patients and their consent was asked for. Patients were asked to free list the reasons for giving or withholding consent. Their depth of understanding was assessed using a questionnaire. Chi-square test was used for statistical analyses. RESULTS: The percentages of those consenting after full disclosure 29/102 (30%) and after partial disclosure 15/50 (30%) were the same. There was a significant (p=0.043) gender difference with a lesser percentage of females (30%) consenting to participation in a trial. Educational status did not alter this percentage. Most patients withheld consent because they did not want to give blood or take a new drug. Understanding of informed consent was poor in those who consented. CONCLUSIONS: The fact that only one-third of subjects are likely to give consent to participate in a trial needs to be considered while planning clinical trials with a large sample size. Gender but not educational status influences the number of subjects consenting for a study. Poor understanding of the elements of informed consent in patients necessitates evolving better methods of implementing consent procedures in India. |
|
dc.publisher |
Medknow Publications |
|
dc.source |
Journal of Postgraduate Medicine |
|
dc.title |
Recruitment of subjects for clinical trials after informed consent: does gender and educational status make a difference? |
|